Fig. 1From: Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatinThe level of CA125 in serum of different groups and pathological types. a The level of CA125 in serum of patients in different groups. b The level of CA125 in serum of patients with different pathological typesBack to article page